Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease. Aamodt WW, Waligorska T, Shen J, Tropea TF, et al. Mov Disord 2021 Sep 4. doi: 10.1002/mds.28779.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aamodt WW, Waligorska T, Shen J, Tropea TF, et al. Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease. Mov Disord 2021 Sep 4. doi: 10.1002/mds.28779.
PMID: 34480363